Our Technologies
Lipoxen has developed a range of proprietary patented technologies that are being used to create a new generation of drug and vaccine products with improved performance. Lipoxen’s technologies include:
PolyXen® for protein drug delivery
PolyXen® is a versatile enabling technology that uses the biopolymer polysialic acid to prolong the active life and improve the pharmacokinetics of therapeutic peptides and proteins, as well as conventional small molecule drugs. PolyXen® is potentially a next generation method to PEGylation for the delivery of protein drugs.
ImuXen® for vaccine delivery
ImuXen® is an advanced enabling technology that uses liposome-based constructs to boost the effectiveness of DNA, protein and polysaccharide vaccines. ImuXen® can achieve protective immunity in a single dose.
VesicALL® for anti-cancer drug delivery
VesicALL® is a highly efficient enabling technology for the formulation of anti-cancer treatment and other drugs using liposomal entrapment. Its proprietary method has increased the range of drugs which can be formulated in this way.